NewcelX NCEL
NASDAQ NCEL
$2.56 -0.39 (-13.22%)
As of: Oct 22, 2026 · 3:59 PM EDT

NewcelX (NCEL) Shares Outstanding (Entity) (2019 - 2025)

Updated

NewcelX's Shares Outstanding (Entity) was 3.84 million in Q4 2025, compared with 154,328 a year earlier.

Analysis

NewcelX (NCEL) Shares Outstanding (Entity) (2019 - 2025) Analysis & Trends

From Q4 2019 onward, NewcelX has reported Shares Outstanding (Entity) for 7 quarters.

  • Shares Outstanding (Entity) shows a five-year compound annual growth rate of 40.7% (FY2020 to FY2025).
  • In earlier years, Shares Outstanding (Entity) was 154,328 in FY2024 (-95.7%), 3.57 million in FY2023 (+81.2%), 1.97 million in FY2022 (+65.4%) and 1.19 million in FY2021 (+71.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 941.36 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.41 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 1.77 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 540.60 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 1.24 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 5.70 Bn
10 NewcelX 9.23 Mn 2.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.80 Mn
Dec 31, 2024 315,954.00
Dec 31, 2023 3.57 Mn
Dec 31, 2022 3.24 Mn
Dec 31, 2021 1.19 Mn
Dec 31, 2020 696,000.00
Dec 31, 2019 696,000.00
API Access

NewcelX Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=NCEL&period=max&api_key=YOUR_API_KEY